Edition:
United Kingdom

People: Biogen Inc (BIIB.OQ)

BIIB.OQ on NASDAQ Stock Exchange Global Select Market

226.39USD
9:00pm BST
Change (% chg)

$-0.79 (-0.35%)
Prev Close
$227.18
Open
$227.28
Day's High
$227.80
Day's Low
$221.56
Volume
1,219,471
Avg. Vol
699,006
52-wk High
$388.67
52-wk Low
$216.13

McKenzie, Paul 

Dr. Paul McKenzie, Ph.D. is Executive Vice President, Pharmaceutical Operations and Technology of Biogen Inc. Prior to that, from February 2016 to June 2016, he served as our Senior Vice President for Global Biologics Manufacturing & Technical Operations. Prior to joining Biogen, beginning in 2008, Dr. McKenzie held a number of positions of increasing responsibility at J&J, including Vice President of R&D for J&J’s Ethicon business and Global Head of Pharmaceutical Manufacturing and Technical Operations, where he led the manufacturing and technical operations team responsible for internal and external manufacturing of Janssen’s pharmaceutical portfolio. He also ran global Development for Janssen R&D, helping to manage pipeline activities from discovery through clinical development and commercialization. Prior to J&J, Dr. McKenzie also held various R&D and manufacturing positions at BMS and Merck, both of which are pharmaceutical companies.

Basic Compensation

Total Annual Compensation, USD 1,397,080
Restricted Stock Award, USD 3,514,450
Long-Term Incentive Plans, USD --
All Other, USD 103,725
Fiscal Year Total, USD 5,015,260

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --